| __timestamp | Amphastar Pharmaceuticals, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 22622695 |
| Thursday, January 1, 2015 | 174172000 | 24863028 |
| Friday, January 1, 2016 | 150976000 | 21351001 |
| Sunday, January 1, 2017 | 149380000 | 53837297 |
| Monday, January 1, 2018 | 187681000 | 16080096 |
| Tuesday, January 1, 2019 | 190434000 | 18525736 |
| Wednesday, January 1, 2020 | 206506000 | 2024000 |
| Friday, January 1, 2021 | 238029000 | 2548000 |
| Saturday, January 1, 2022 | 250127000 | 61556000 |
| Sunday, January 1, 2023 | 293274000 | 188157000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Amphastar Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited from 2014 to 2023. Over this period, Amphastar's cost of revenue has shown a steady increase, peaking in 2023 with a 46% rise from its 2014 figures. In contrast, Telix Pharmaceuticals experienced a dramatic surge, with its cost of revenue in 2023 being over eight times higher than in 2014. This stark difference highlights Telix's aggressive growth strategy, possibly driven by increased production or expansion efforts. Meanwhile, Amphastar's consistent growth suggests a stable operational model. These insights provide a window into the financial strategies of these companies, offering valuable information for potential investors and industry analysts.
Cost Insights: Breaking Down Eli Lilly and Company and Telix Pharmaceuticals Limited's Expenses
Cost of Revenue Trends: AstraZeneca PLC vs Amphastar Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Lantheus Holdings, Inc. and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Cytokinetics, Incorporated and Amphastar Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Amneal Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and Ionis Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Telix Pharmaceuticals Limited vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Vericel Corporation
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Wave Life Sciences Ltd.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.